glp-1 covid drugs calm inflammation beyond diabetes and weight loss GLP-1 Receptor Agonists: New Frontiers

The possibility that GLP-1 receptor agonists may be effective for some substance use disorders is promising, but we need large randomized controlled trials to confirm benefit and clarify for whom they work best, he says

10.1038/s41575-019-0158-2 54 LiC.XiaJ.DengJ.JiangJ

Existing anti-diabetic drugs contribute towards improving glycemic control by either increasing the bodys sensitivity to insulin, enhancing insulin secretion or reducing renal glucose reabsorption

Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study

Xultophy 100/3.6 combines insulin degludec 100 units/mL with liraglutide 3.6 mg/mL

Tirzepatide (Mounjaro/Zepbound) remains approved exclusively for adults aged 18 years and older, as pediatric safety and efficacy data are pending from ongoing phase 3 trials in adolescents with type 2 diabetes [181]